Cha Albert — SEC insider filings

SEC reporting owner CIK 1397906. 8 insider filings on record with FilingPulse; latest filed 2026-10-15.

Transaction summary — filings shown

Covers all 8 filings on record, filed 2020-10-02 to 2026-10-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Frazier Life Sciences Acquisition Corp. II (FLSC)Chief Executive Officer, Director, 10% owner21 leg · 300,000 sh · $3,000,000——
KalVista Pharmaceuticals, Inc. (KALV)Director62 legs · 115,686 sh · $1,994,0681 leg · 18,000 sh · $189,0508

Insider filings — Cha Albert

FiledFormIssuerReported transactionsSource
2026-10-154Frazier Life Sciences Acquisition Corp. II (FLSC)
jointly with Frazier Life Sciences Holdings II LLC, Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C.
Purchase (P): 300,000 @ $10EDGAR
2026-10-133Frazier Life Sciences Acquisition Corp. II (FLSC)
jointly with Frazier Life Sciences Holdings II LLC, Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C.
Holdings only — no transactions reportedEDGAR
2023-09-284KalVista Pharmaceuticals, Inc. (KALV)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2023-09-134KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 6,000 @ $6.71 · Option exercise (M): 12,000 @ $7.88 · Sale (S): 18,000 @ $10.50 · Option exercise (M): 6,000 (derivative) @ $0 · Option exercise (M): 12,000 (derivative) @ $0EDGAR
2022-10-174KalVista Pharmaceuticals, Inc. (KALV)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-10-014KalVista Pharmaceuticals, Inc. (KALV)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2020-11-034KalVista Pharmaceuticals, Inc. (KALV)Purchase (P): 68,255 @ $17.17 · Purchase (P): 47,431 @ $17.34EDGAR
2020-10-024KalVista Pharmaceuticals, Inc. (KALV)Grant/award (A): 7,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1397906 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs